Lifeward (LFWD) said Thursday the US Food and Drug Administration has cleared ReWalk 7, the newest version of its personal exoskeleton device.
According to Lifeward, ReWalk 7 is a wearable device that allows users with spinal cord injury to stand and walk. The company said sales of ReWalk 7 in the US will start "as soon as the product is available."
Lifeward shares climbed by more than 70% in early trading on Thursday.